Streetbeat News

Stock Prices

ZEPP

Zepp Health (NYSE:ZEPP) reported Q3 earnings with EPS of $0.03, meeting estimates, but with a revenue decline of $86.98 million year-over-year. The company's past earnings performance shows a pattern of not meeting EPS estimates, with the last quarter missing by $0.14, yet the share price remained stable the following day.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 10:45 am

A

KEYS

MSI

PNRG

ZM

U.S. stock futures are trading lower on Monday, with investor focus on Agilent Technologies (A), Masimo Corporation (MSI), Zoom Video Communications (ZM), PrimeEnergy Resources Corporation (PNRG), and Keysight Technologies (KEYS) due to earnings reports and FDA clearance news. Agilent is expected to report earnings after the bell, with a forecast of $1.35 per share on $1.67 billion revenue. Masimo's W1 medical watch received FDA clearance, and its shares rose slightly in after-hours. Zoom Video is anticipated to post earnings of $1.08 per share on $1.12 billion revenue after market close. PrimeEnergy reported a decrease in earnings and revenue compared to the previous year. Keysight is also expected to report earnings with an estimate of $1.87 per share on $1.30 billion revenue.

Portfolio Pulse from Lisa Levin

November 20, 2023 | 10:44 am

BABAF

Alibaba Group Holding Limited (OTC:BABAF) has canceled the spinoff of its cloud business, leading to mixed reactions from analysts and a significant drop in market value. Morgan Stanley removed Alibaba from its top pick and lowered the price target from $125 to $110. Bernstein reduced their price target from $100 to $93, while Barclays maintained a $138 price target, supporting the decision amidst regulatory uncertainties. JPMorgan kept a $150 price target but expressed concerns over the cloud business's growth. The cancellation follows U.S. chip curbs affecting Chinese companies, contributing to a $20 billion loss in Alibaba's market value.

Portfolio Pulse from Benzinga Neuro

November 20, 2023 | 10:43 am

SPB

Wells Fargo analyst Sam Reid downgraded Spectrum Brands Holdings (NYSE:SPB) from Overweight to Equal-Weight and set a price target of $73.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:43 am

CHGG

Morgan Stanley analyst Josh Baer has downgraded Chegg (NYSE:CHGG) from Equal-Weight to Underweight and reduced the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:38 am

BA

Deutsche Bank analyst Scott Deuschle has upgraded Boeing (NYSE:BA) from Hold to Buy and set a price target of $270.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:36 am

MSFT

Microsoft Corp. (NASDAQ:MSFT) shares saw a strong premarket advance on Monday, potentially reversing Friday's losses. This follows the news that OpenAI co-founder Sam Altman, who was ousted on Friday, will join Microsoft, along with ex-president Greg Brockman and their team. Microsoft CEO Satya Nadella expressed commitment to the OpenAI partnership and confidence in Microsoft's product roadmap. The company has integrated OpenAI's technology into its products and invested $10 billion in OpenAI earlier this year. Microsoft's stock rose 2.56% to $379.33 in premarket trading.

Portfolio Pulse from Shanthi Rexaline

November 20, 2023 | 10:35 am

ADA-USD

MSFT

Charles Hoskinson, founder of Cardano, invited former OpenAI CEO Sam Altman to collaborate on a decentralized large language model project that could integrate with Cardano's Partner Chain ecosystem. Meanwhile, Microsoft has already brought Altman and Greg Brockman onboard to lead a new advanced AI research team after Altman's departure from OpenAI. ADA's price was up 6% at the time of reporting.

Portfolio Pulse from Mehab Qureshi

November 20, 2023 | 10:32 am

DNUT

JP Morgan analyst John Ivankoe downgraded Krispy Kreme (NASDAQ:DNUT) from Overweight to Neutral and set a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:09 am

SIX

Jefferies analyst David Katz has upgraded Six Flags Entertainment (NYSE:SIX) from Hold to Buy and increased the price target from $25 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:08 am